We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the pricing of its...
- Data supports CLD-101 and CLD-201’s first-in-class use of stem cells to protect and potentiate antitumor virotherapies designed improve antitumor activity in the clinic. Calidi Biotherapeutics...
City of Hope, a leader in cancer research and treatment, was awarded $5.3 million from California Institute for Regenerative Medicine (CIRM) to develop a treatment for metastatic ovarian cancer...
City of Hope was awarded $5.3 million from CIRM to develop a treatment for metastatic ovarian cancer using Calidi’s licensed lead asset, CLD-101. The grant highlights CIRM’s continued support of...
– Preclinical models have demonstrated the ability to resist oncolytic virus inactivation by human serum and target diverse tumor types – Novel therapeutic approach allows for ease of...
Antonio Chiocca, M.D., Ph.D., Chair, Department of Neurosurgery at Brigham and Women’s Hospital, Co-Director, Institute for the Neurosciences, and Professor of Neurosurgery at Harvard Medical...
Company to also share progress with cell-based virotherapy platforms for advanced solid tumors Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the appointment of...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0649 | 38.5620915033 | 0.1683 | 0.3201 | 0.1435 | 1016694 | 0.1619772 | CS |
| 4 | -0.3405 | -59.3515774795 | 0.5737 | 0.83 | 0.1435 | 1351642 | 0.35761552 | CS |
| 12 | -0.5476 | -70.1331967213 | 0.7808 | 1.68 | 0.1435 | 699550 | 0.54783801 | CS |
| 26 | -2.1868 | -90.3636363636 | 2.42 | 2.64 | 0.1435 | 366269 | 0.67193793 | CS |
| 52 | -4.2768 | -94.8292682927 | 4.51 | 5 | 0.1435 | 299928 | 0.77314811 | CS |
| 156 | -4.2768 | -94.8292682927 | 4.51 | 5 | 0.1435 | 299928 | 0.77314811 | CS |
| 260 | -4.2768 | -94.8292682927 | 4.51 | 5 | 0.1435 | 299928 | 0.77314811 | CS |
ErnieBilco
6 days ago
Legend431
3 weeks ago
Triple nickle
3 weeks ago
2020trader
3 weeks ago
glenn1919
2 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
